Is Alemtuzumab available in China?

The original drug of Alemtuzumab (Alemtuzumab) is not currently on the market in China, so patients cannot purchase this drug through relevant channels in China. There is only the French version of the original drug available abroad, and its price is still very expensive. Alemtuzumab was approved by the U.S. Food and Drug Administration (FDA) in 2001 and is marketed as LEMTRADA for the treatment of multiple sclerosis (MS) and as CAMPTAH for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). Alemtuzumab doses forB-cell chronic lymphocytic leukemia are much higher than those for multiple sclerosis and are given more frequently.